Nicomac Clean Rooms Far East Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 24 Year, 22 Days
- Last Filing with ROC 31 Mar 2016
- Satisfied Charges ₹ 6.43 Cr
- Revenue Growth 34.19%
- Profit Growth 147.21%
- Ebitda 125.80%
- Net Worth 84.12%
- Total Assets 61.09%
About Nicomac Clean Rooms Far East
Company Details
- Location Ameerpet, Hyderabad., Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U29308TG2001PTC036142
- Company No.
036142
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2001
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Nicomac Clean Rooms Far East?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nigris Tomaso  | Director | 24-Feb-2003 | Current |
Narasimha Bandreddi  | Director | 31-Jan-2001 | Current |
| Gundala Ramesh | Director | 31-Oct-2007 | Current |
Financial Performance of Nicomac Clean Rooms Far East.
Nicomac Clean Rooms Far East Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 34.19% increase. The company also saw a substantial improvement in profitability, with a 147.21% increase in profit. The company's net worth Soared by an impressive increase of 84.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nicomac Clean Rooms Far East?
In 2016, Nicomac Clean Rooms Far East had a promoter holding of 5.00% and a public holding of 95.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Louis Pharmaceuticals Private LimitedNarasimha Bandreddi is a mutual person
Moreschi Asia Doors Private LimitedNarasimha Bandreddi and Gundala Ramesh are mutual person
- Bnr & Sons Advisory Services Private Limited
Narasimha Bandreddi is a mutual person
- Mallika Hortigreen Llp
Gundala Ramesh is a mutual person
- Nicomac Taikisha Clean Rooms Private Limited
Gundala Ramesh is a mutual person
Charges (Loans)
₹0
₹6.43 Cr
Charges Breakdown by Lending Institutions
- Syndicate Bank : 6.43 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2007 | Syndicate Bank | ₹4.30 M | Satisfied |
| 12 Aug 2005 | Syndicate Bank | ₹6.00 Cr | Satisfied |
How Many Employees Work at Nicomac Clean Rooms Far East?
Unlock and access historical data on people associated with Nicomac Clean Rooms Far East, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nicomac Clean Rooms Far East, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nicomac Clean Rooms Far East's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
